Last Updated: Apr 02, 2016
- Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.
Mork Maureen E, et al. Familial cancer 2016 3 - Dual targeting of HER3 and EGFR in colorectal tumors might overcome anti-EGFR resistance.
Temraz Sally, et al. Critical reviews in oncology/hematology 2016 3 - [Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].
Fournier C, et al. Revue des maladies respiratoires 2016 3 - Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram Süleyman, et al. Gene 2016 3 - A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
Penson R T, et al. Gynecologic oncology 2016 4 (1) 108-12 - Germline mutations of the DNA repair pathways in uterine serous carcinoma.
Frimer Marina, et al. Gynecologic oncology 2016 4 (1) 101-7 - Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Myers Andrea P, et al. Gynecologic oncology 2016 4 (1) 43-8 - At least two well-spaced samples are needed to genotype a solid tumor.
Siegmund Kimberly, et al. BMC cancer 2016 0 (1) 250 - Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants.
Pilling Luke C, et al. Aging 2016 3 - Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study.
Çolak Yunus, et al. Thorax 2016 3 - Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
Stewart Sherri L et al. Journal of women's health (2002) 2016 Mar 25(3) 235-41 - Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations.
Henry N Lynn et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mar - Translating genomics: cancer genetics, public health and the making of the (de)molecularised body in Cuba and Brazil.
Gibbon Sahra et al. Histo´ria, cie^ncias, sau´de--Manguinhos 2016 Mar 23(1) 95-112 - NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.
Endris Volker et al. Virchows Archiv : an international journal of pathology 2016 Mar - Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.
Hannouf M B et al. The pharmacogenomics journal 2016 Mar - RESEARCH ETHICS. Ethics review for international data-intensive research.
Dove Edward S et al. Science (New York, N.Y.) 2016 Mar 351(6280) 1399-400 - Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.
Benitez-Buelga Carlos, et al. Oncotarget 2016 3 - Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-Analysis.
Wu Zhitong, et al. Medicine 2016 3 (12) e3129 - Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding Hui, et al. Medicine 2016 3 (12) e2941 - Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.
Spans Lien, et al. Oncotarget 2016 3 - Gene by Environment Interaction Linking the Chromosome 15q25 Locus With Cigarette Consumption and Lung Cancer Susceptibility - Are African American Affected Differently?
Hopkins R J, et al. EBioMedicine 2016 2 13-4 - Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran.
Mohammadzadeh Ghorban, et al. Advanced biomedical research 2016 0 26 - Liver X Receptor-? polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo.
Agarwal Silky, et al. Meta gene 2016 6 33-6 - Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy.
Matsusaka Satoshi, et al. Genes & cancer 2016 1 (1-2) 27-35 - An Individual with Both MUTYH-Associated Polyposis and Lynch Syndrome Identified by Multi-Gene Hereditary Cancer Panel Testing: A Case Report.
Cohen Stephanie A, et al. Frontiers in genetics 2016 0 36 - Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.
Dominguez-Valentin Mev, et al. BMC urology 2016 0 (1) 15 - Tier 1 Genomic Applications Toolkit for Public Health Departments
Disease: Multiple Diseases; Type: Tools; State: Multiple States - Nowhere to hide: Blood-based cancer monitoring gets ever more sensitive
K Conger, Stanford, March 28, 2016 - Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
Lasorsa Vito Alessandro, et al. Oncotarget 2016 3 - Analysis of ultra-deep targeted sequencing reveals mutation burden is associated with gender and clinical outcome in lung adenocarcinoma.
Xiao Dakai, et al. Oncotarget 2016 3
- Hot Topics (1033)
- Genomics & Health Impact Scan (0)
- AMD Weekly Clips(34)
- HuGE (29257)
- AMD Weekly Clips (0)
No hay comentarios:
Publicar un comentario